Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 625, pseudogene (RN7SL625P)

Target
RN7SL625P
Molecular classification
Other (pseudogene; non-coding RNA locus)
01

Overview

RNA, 7SL, cytoplasmic 625, pseudogene (RN7SL625P) is a genomic region in humans that represents a processed or truncated copy of the 7SL RNA gene. The 7SL RNA is an essential component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in cotranslational protein targeting to the endoplasmic reticulum[5]. However, RN7SL625P itself does not encode a functional SRP RNA. Instead, it is a non-coding, non-functional pseudogene sequence likely derived by reverse transcription and integration of RNA back into genomic DNA[7][8]. RN7SL-type pseudogenes are present in large numbers throughout the human genome, but do not produce protein or functional RNA, nor do they act as therapeutic targets. There is no current evidence implicating RN7SL625P in any clinical or regulatory role, nor is it involved in disease pathogenesis or as a biomarker[1][7][8].

Other names
RN7SL625P7SL pseudogeneRNA, 7SL, cytoplasmic 625, pseudogene
02

Mechanism of action

None (not targeted by drugs)

03

Biological functions

None established; pseudogenes like RN7SL625P do not encode functional RNA or protein
04

Disease associations

None described for RN7SL625P directly; however, some pseudogenes have regulatory roles in disease (see context below), but RN7SL625P itself is not linked to disease or cancer
05

Safety considerations

None (no therapeutic targeting, no clinical implications)
06

Interacting drugs

None known (not a functional target)
07

Biomarkers

None (not used in clinical biomarker settings)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 625, pseudogene (RN7SL625P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 625, pseudogene (RN7SL625P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call